BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hao WW, Xu F. KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling. World J Gastrointest Oncol 2022; 14(7): 1239-1251 [PMID: 36051093 DOI: 10.4251/wjgo.v14.i7.1239]
URL: https://www.wjgnet.com/1007-9327/full/v14/i7/1239.htm
Number Citing Articles
1
Helin Zhang, Xingxing Zhang, Yuelin Zhang, Dali Han, Hualan Ha, Biao Zhang, Panfeng Shang. Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder CancerMolecular Biotechnology 2024;  doi: 10.1007/s12033-024-01149-y
2
Guohu Han, Shuangshuang Zhou, Junjun Shen, Yuanyuan Yang, Xuyu Bian, Yahu Li, Rui Ling, Rongrui Liang, Min Tao. The role of TMEM26 in disrupting tight junctions and activating NF-κB signaling to promote epithelial-mesenchymal transition in esophageal squamous cell carcinomaClinics 2023; 78: 100276 doi: 10.1016/j.clinsp.2023.100276
3
Yang He, Pengzhan He, Shimin Lu, Weiguo Dong. KIFC3 Regulates the progression and metastasis of gastric cancer via Notch1 pathwayDigestive and Liver Disease 2023; 55(9): 1270 doi: 10.1016/j.dld.2023.02.014
4
Shimin Lu, Yinghui Liu, Shan Tian, Yang He, Weiguo Dong. KIFC3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR pathwayExperimental Cell Research 2023; 426(1): 113564 doi: 10.1016/j.yexcr.2023.113564